Advanced Search
Contact | Corporate | Help

Daily news email for August 02, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

 b3c newswire
CEVEC Licenses its Proprietary Human Cell Lines to Paragon Bioservices, Inc.

Cambridge Research Biochemicals Signs Deal with LI-COR Biosciences for Infrared Dye Labelled ...

2. Laupheimer Zelltage Attracts Top Scientists to Discuss Recent Advances in Biomanufacturing

Antisense Pharma Receives FDA Orphan Drug Designation for Trabedersen to Treat Malignant Melanoma

Sartorius Stedim Biotech Recognized as Innovations Honoree for FlexMoSys

 BioSpace
Slower, Longer Sperm Outcompete Faster Rivals, Syracuse University Study

Peptide Controls Blood Sugar in People With Congenital Hyperinsulinism, Children's Hospital of Philadelphia Study

Alzheimer's Villain Cures Multiple Sclerosis in Mice, Stanford University Study

Dr. Reddy's Laboratories Ltd.'s Reopens Mexico Plant

ISS Switches Sides, Backs Icahn in Forest Laboratories, Inc. Fight

BioSpace - Breaking News
Acura Pharmaceuticals, Inc. Supports the Stop Tampering of Prescription Pills Act of 2012

Allergan Inc. Earnings Up 20% With Help From Botox

Bayer HealthCare Guilty of Breaching ABPI Codes

Sigma-Aldrich Corporation's and Autism Speaks Expand Collaboration to Develop Rat Models for Translational Autism Research

Private Consortium Buys Former Pfizer Inc. Site in Sandwich

Biotech News - Business Wire
ACT Announces First Dry AMD Patient Treated with Higher Dosage of Embryonic Stem Cell-Derived RPE Cells

GenMark Diagnostics Schedules Second Quarter 2012 Financial Results and Conference Call for August 7, 2012

Suppliers Being Accepted to Showcase Advances in Healthcare at National Event

Research and Markets: US Biotechnology Sector: Industry Profile

Teleflex Announces Quarterly Dividend

 Biotech News - PR Newswire
It's Indiana State Fair Season: New BioCrossroads Report Emphasizes Opportunities in Food and Agriculture Innovation

Vitamin D Deficiency Disorders Global Clinical Trials Review, H2, 2012

Ekahau - A Preferred Provider of Real-Time Location Solutions - Is Awarded an Agreement with the Premier Healthcare Alliance

Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires

Yongye International to Report Second Quarter 2012 Financial Results on August 9, 2012
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

 Burrill Report
India Preparing to Introduce Price Controls

Amarin Wins FDA Approval of Vascepa

Hyperion Therapeutics Goes Public

Supreme Court Ruling on Healthcare Reform Will Lower Costs

California's Stem Cell Agency Approves $150 Million Grants

 CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
Clinical Trials - Business Wire
UPenn Doses First Two Dogs in ADXS-HER2 Canine Osteosarcoma Study

NTRR Evaluates Bio-Energy Infusion of New Male Enhancement Pill

Telcare Signs Licensing Agreement to Market GlucoDynamix-ADMS

Conventus Orthopaedics Completes Enrollment in Multi-Center European Clinical Study of Novel Fracture Implant

Research and Markets: Clinical Laboratory Testing Volume 2: Key Players for Laboratory Testing, Business Trends and Strategies

 Clinical Trials - PR Newswire
Medical College Of Wisconsin To Study New Incontinence Device

Safeway Shoppers 'Make A Muscle' For Muscular Dystrophy Association

MIOT Hospitals Performs World's First Cardiac Multi-Surgery on a 14-Year-old boy

United States Sports Academy Researchers Present Clinical Trial Results For MusclePharms' Assault Pre-Workout Nutritional Supplement At National Strength & Conditioning Association's National Conference

New Research Shows Prostate Cancer Testing Prevents 17,000 Men from Developing Advanced Prostate Cancer

 CNN Top Stories
Louganis: Didn't think I'd see 30

Taxes on Olympic winnings

Photos: Day 6

Badminton player quitting the sport

Boy dies from brain-eating amoeba
Contract Pharma
Adimab, Mersana in ADC Pact

PAREXEL Adds Outcomes Research Expert

Financial Report: West

Gilead, Generic Partners in HIV Pact

Halo Completes Mirabel Acquisition

 FDA Drugs- What's New
Comunicado de la FDA sobre la seguridad de los medicamentos: Riesgo de convulsiones en pacientes con esclerosis múltiple que toman Ampyra (dalfampridine)

Comunicado de la FDA sobre la seguridad de los medicamentos: Riesgo de convulsiones en pacientes con esclerosis múltiple que toman Ampyra (dalfampridine)

FDA Drug Safety Communication: Seizure risk for multiple sclerosis patients who take Ampyra (dalfampridine)

Comunicado de la FDA sobre la seguridad de los medicamentos: Nueva información sobre la prolongación del intervalo QT con ondansetrón (Zofran)

Comunicado de la FDA sobre la seguridad de los medicamentos: Nueva información sobre la prolongación del intervalo QT con ondansetrón (Zofran)

 FDA News - Business Wire
ARIAD Reports Second Quarter 2012 Financial Results and Development Progress

A.P. Pharma Announces Second Quarter 2012 Financial Results and Highlights Recent Corporate Progress

BioCryst Provides Corporate Update and Reports Second Quarter 2012 Financial Results

Baxter Confirms Receipt of Complete Response Letter on HyQ

Actuated Medical Obtains FDA Clearance for TubeClear, a System That Clears Patient Feeding and Decompression Tubes
FDA Press Releases
Food Safety Guides for Groups Most Vulnerable to Foodborne Illness Now Available

FDA warns consumers not to eat cantaloupes from Burch Equipment LLC of North Carolina

FDA approves Tudorza Pressair to treat chronic obstructive pulmonary disease

FDA: More than 150 antiretroviral drugs available through PEPFAR for worldwide HIV/AIDS relief

FDA warns consumers not to eat shellfish from Oyster Bay Harbor, Nassau County, NY

 FDA Vaccines, Blood and Biologics - What's New
Cord Blood Banking - Information for Consumers

Package Insert - Twinrix

Direct Recall Classification Program

Draft Guidance for Industry: Amendment to Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products

Procleix Ultrio Plus Assay

 FierceBiotech
RIP: After long illness, Genta finally opts to liquidate

Report: Bristol exec nabbed on insider trading charge

Pharming continues restructuring with a round of layoffs

Halozyme blitzed as FDA rejects Baxter drug, halts combo trial

R&D shift sees new jobs in China as Western ops are restructured
FierceBiotech IT
AstraZeneca adopts search engine for scientists

Medidata lands record $100M deal with a Big Pharma

AZ blames IT problems for production backup

Models shed light on cocaine-curbing enzymes

AZ's R&D information chief eyes improved trial success

 FierceBiotech Research
Celgene and Eisai drugs jointly killed kidney and breast cancer cells

New white blood cell variation is provocative cancer vaccine target

Another shot at treating Alzheimer's with Dimebon

CIRM favors teamwork with $150M in new stem cell grants

17 universities win NIH cash for tissue chip/drug safety testing

 FiercePharma
Sanofi, Otsuka amp up their Turkish ambitions

Gilead inks low-cost HIV drug deal with generics makers

Feds charge Bristol-Myers exec with insider trading

Glass Lewis stands up for Forest's board slate

Shire, UCB see new-drug growth as Allergan, Hospira fall short
FiercePharma Manufacturing
Hospira CEO Ball says it's getting 'gators' under control

CMC nabs Xoma's Bay Area plant

Rexam eyes factory growth, despite lagging healthcare sales

UPDATED: Regeneron expands plant

Regeneron expands plant to capture surge in Eylea sales

 FierceVaccines
Alnylam gets $3.2M milestone from GSK for vax tech

Old whooping cough vax more effective than new one

Old whooping cough vax more effective than new

AstraZeneca wins Fluenz contract in U.K.

Survey: U.S. females fail to finish Merck and GSK HPV shots

Health News - BizJournals.com
Rothman Institute adds physicians, new offices

Medrad co-founder Dr. Mark Wholey to join AGH

Hanger's 2Q revenue up 7%

MPS' Thornton to stay through 2015

New office rises in Austin's medical district
Health News - CNBC
More U.S. women choosing IUDs for birth control

Bristol's Hep C Drug Blowup May Benefit These Stocks

Teva profit up on demand for generic, brand drugs

Cigna 2Q profit slips 3 pct, 2012 forecast rises

Gilead signs deals with Indian companies for low-cost HIV drug

 Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

 Inside Industry - Gen
A Blow Against Biowarfare: Elusys Awarded $50.2M More for Inhalational Anthrax Treatment

Rat Studies Reveal Unexpected Autism Gene Function

Pharming Sharpens Ax as Layoffs Loom

Covidien Opens $45M R&D Facility in Shanghai

FEI Makes Third Acquisition of Year
Marketwire - Pharma and Biotech
Acura Pharmaceuticals Supports the Stop Tampering of Prescription Pills Act of 2012

Druggability Technologies Appoints Louis Scotti as Chief Business Development Officer

Burrill & Company Announces Second Close of Burrill Capital Fund IV, L.P.

BIOLASE Announces Distribution Agreement With 3Shape Corporation

EnWave Signs Market Development Agreement with Milne Fruit Products Inc.

 MassBio News
State, Local and Industry Officials Join KeraFAST to Open New Headquarters in Boston, MA

MLSC 2012 Capital Program Announcement

2012 Tax Incentive Program Announcement

Q&A With Jonathan Thomas

Policy Update

 Medical Pharma - PR Newswire
Mylan Signs Agreement with Gilead to Accelerate Access to Generic Single and Fixed-Dose Combination ARVs Containing Emtricitabine

Perrigo Company Will Release Fourth Quarter And Fiscal Year 2012 Results On August 16, 2012

"Everyday Matters" Brings Unique Resources to People Affected by Multiple Sclerosis

Wellesse® Premium Liquid Supplements Partners with Lifetime TV's Balancing Act to Bring Easy Solutions for Healthier Living

Tips For Overcoming Cancer Fatigue According To Matrix Home Care
National Center for Biotechnology Information
GenBank Submission Tools Announcements

GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

 Nature Biotechnology
Incorporating biomarkers into clinical trial designs: points to consider

TAL effector RVD specificities and efficiencies

Gene therapy matures in the clinic

From academic solos to industrial symphonies

Reading cancer's blueprint

 New York Times- Biotechnology
Novel Blood Treatment Lures Athletes in Pain to Germany

Athletes With Chronic Pain Turn to Novel Blood Treatment

Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

Craig Venter’s Bugs Might Save the World

Study Backs Continuous Prostate Cancer Treatment
New York Times- Pharmaceuticals
Ancestral Remedies to the Rescue

Cost-Cutting Helps Pfizer Beat Expectations

Imagine a World Without AIDS

Helping Patients in Need

The Long, Uphill Battle Against AIDS

 OnBioVC
Stemgent, Inc.: Series C $6.3M

Genalyte, Inc.: Series A $11.8M

Relievant Medsystems, Inc.: Series D $30M

ImaginAb, Inc.: Series A $12.5M

BiO2 Medical, Inc.: Series B $13.7M

 Outsourcing-Pharma
Wockhardt targets CMO space for diversification

Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles

Home visits = regulatory thumbs up ResearchNurses.co thinks so

Home visits are the key to patient retention, says ResearchNurses.co

Kemwell and Boehringer set to finish biologics plant in India
Pharma News - Business Wire
IGI Laboratories to Hold Conference Call for 2nd Quarter 2012 Results

Pernix Therapeutics to Report Second Quarter 2012 Financial Results on August 14, 2012

Resumen: TFS implanta el sistema de gestión de ensayos clínicos de Medidata Solutions para desarrollar sus operaciones en toda la creciente red de sitios internacionales

Accenture to Expand Clinical and Regulatory Information Management Services and Software Capabilities with Agreement to Acquire Octagon Research Solutions

Samenvatting: TFS neemt klinisch managementsysteem van Medidata Solutions in gebruik

 Pharma News - PharmiWeb
Innovative and Secure Cloud Based Archiving Solution for European Hospitals

Bring the Vote Home Initiative Helps Seniors, Home-Bound Patients Exercise Their Right to Vote During 2012 Election Cycle

Jersey Shore's Matthew Kaufman, M.D. Is Selected To Present At The European Respiratory Society's 2012 Vienna Congress

FRC Action: 'President Obama to freedom of religion: Nertz to you!'

Safra announces offer to purchase publicly held registered B shares of Sarasin

 Pharma News - PR Newswire
FluMist® (Influenza Vaccine Live, Intranasal) Begins Shipping For 2012-2013 Influenza Season

Test Results Show Unprecedented Achievement for Marburg Drug Candidate

New Study Finds Use of Generic Prescription Drugs Saved Consumers and the U.S. Health Care System $1 Trillion over Past Decade

Par Pharmaceutical Companies Reports Second Quarter 2012 Results

CakeHealth Integrates with GoodRx To Help Users Find The Best Deals On Prescription Drugs
Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

 PR Leap - Biotech
Romer Labs Launches New Website

SHEL LAB Introduces the Bactrox Chamber

Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

 PRWeb - Biotechnology
RAPS Publishes New Edition of Fundamentals of EU Regulatory Affairs

Report Warns Olympic Visitors of Bed Bugs; MyCleaningProducts...

DNA Genotek Inc. and BioServe Biotechnologies, Ltd. to Support Genetic...

Tackling the Challenges Involved with Protein Biomarkers

In-Pipe Technology will Host Two Webinars Discussing how In-Pipe's...
PRWeb - Pharmaceuticals
Advanced Wound Care Products Not Reaching Their Potential Value or...

MJQLAW Filing Lawsuits on Behalf of Women Injured By Transvaginal Mesh

Judge in MDL Actos Litigation Sets More Timelines and Dates in...

Healthcare Solutions to Present at the 10th Annual California Workers...

DTC Perspectives Names 2012 DTC Hall of Fame Class

 Scientific American
Beak Heat: Evolutionary Theory of Bird Bills May Need Revision

Why Great Olympic Feats Raise Suspicions

Beak Heat: Evolutionary Theory of Bird Bills Need May Need Revision

Facet-Lift: Self-Assembling Nanoparticles May Provide Key to New Materials

High-Profile Geneticists Post Findings on Popular Pre-Publication Site

 Sports - ESPN Basketball
UCF's Jones optimistic following NCAA sanctions

Wake Forest to play two exhibitions in Canada

Former coaches Pearl, Greenberg joining ESPN

Colangelo still hopes Coach K will be back in '16

Iona recruit Haynes shot and killed in Chicago
Sports News - ESPN
NDSU RB accused of driving offense charges

Indiana to sit 2 starters 1 game for rules breach

Alabama will build $9M athletic training facility

Oklahoma State OL Bowie chooses to transfer

Iowa dismisses RB Johnson after police run-ins

 Xconomy Life Sciences
Genomatica Withdraws IPO, Instead Raises $41.5M in Private Financing

OncoGenex Waits, and Waits, For Data on Prostate Cancer Drug

Enlight Bio's Knode Advances Social Network for Pharma

Regulatory Concerns Over Halozyme's Flagship Product Trigger Selloff

Gladstone, Sage Bionetworks Top Best Places to Work List

 Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)


SourceSolution © 2008-2012